<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">vtio</journal-id><journal-title-group><journal-title xml:lang="ru">Вестник трансплантологии и искусственных органов</journal-title><trans-title-group xml:lang="en"><trans-title>Russian Journal of Transplantology and Artificial Organs</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1995-1191</issn><publisher><publisher-name>Academician V.I.Shumakov National Medical Research Center of Transplantology and Artificial Organs", Ministry of Health of the Russian Federation</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15825/1995-1191-2024-2-73-81</article-id><article-id custom-type="elpub" pub-id-type="custom">vtio-1762</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Донорство органов</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Organ Donation</subject></subj-group></article-categories><title-group><article-title>Гипотермическая машинная перфузия  донорской почки с использованием  опытного раствора на основе декстрана-40  и ортотопическая трансплантация  (экспериментальное исследование)</article-title><trans-title-group xml:lang="en"><trans-title>Hypothermic machine perfusion of a donor  kidney using an experimental dextran-40-based  preservation solution and orthotopic transplantation (experimental study)</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шестакова</surname><given-names>В. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Shestakova</surname><given-names>V. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Тверь</p></bio><bio xml:lang="en"><p>Tver</p></bio><email xlink:type="simple">Shestvg@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Богданов</surname><given-names>В. К.</given-names></name><name name-style="western" xml:lang="en"><surname>Bogdanov</surname><given-names>V. K.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Павлов</surname><given-names>Р. Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Pavlov</surname><given-names>R. D.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Тверь</p></bio><bio xml:lang="en"><p>Tver</p></bio><email xlink:type="simple">roma.pavlov.2002@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Терехов</surname><given-names>В. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Terekhov</surname><given-names>V. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Терехов Василий Максимович</p><p>170100, Тверская область, Тверь, ул. Советская, д. 4</p><p>Тел. (904) 015-84-76</p></bio><bio xml:lang="en"><p>Tver</p></bio><email xlink:type="simple">terekhov200002@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Тимановский</surname><given-names>А. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Timanovsky</surname><given-names>A. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Тверь</p></bio><bio xml:lang="en"><p>Tver</p></bio><email xlink:type="simple">andrei.timanovsky@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Жариков</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Zharikov</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><email xlink:type="simple">Zharikof94@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шибаев</surname><given-names>А. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Shibaev</surname><given-names>A. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Тверь</p><p>Москва</p></bio><bio xml:lang="en"><p>Tver</p><p>Moscow</p></bio><email xlink:type="simple">Anshibaev@rambler.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Грудинин</surname><given-names>Н. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Grudinin</surname><given-names>N. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><email xlink:type="simple">zbignev.religa@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБОУ ВО «Тверской государственный медицинский университет» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Tver State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБУ «Национальный медицинский исследовательский центр трансплантологии и искусственных органов имени академика В.И. Шумакова» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Shumakov National Medical Research Center of Transplantology and Artificial Organs</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>ФГБОУ ВО «Тверской государственный медицинский университет» Минздрава России; ГБУЗ МО «Московский областной научно-исследовательский клинический институт имени М.Ф. Владимирского»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Tver State Medical University; Vladimirsky Moscow Regional Research and Clinical Institute</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>05</day><month>04</month><year>2024</year></pub-date><volume>26</volume><issue>2</issue><fpage>73</fpage><lpage>81</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Шестакова В.Г., Богданов В.К., Павлов Р.Д., Терехов В.М., Тимановский А.С., Жариков А.А., Шибаев А.Н., Грудинин Н.В., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Шестакова В.Г., Богданов В.К., Павлов Р.Д., Терехов В.М., Тимановский А.С., Жариков А.А., Шибаев А.Н., Грудинин Н.В.</copyright-holder><copyright-holder xml:lang="en">Shestakova V.G., Bogdanov V.K., Pavlov R.D., Terekhov V.M., Timanovsky A.S., Zharikov A.A., Shibaev A.N., Grudinin N.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.transpl.ru/vtio/article/view/1762">https://journal.transpl.ru/vtio/article/view/1762</self-uri><abstract><p>Целью данного исследования являлась оценка эффективности гипотермической машинной перфузии донорской почки, полученной от асистолического донора, опытным раствором на основе декстрана-40 при последующей ортотопической трансплантации на модели кролика.</p><sec><title>Материалы и методы</title><p>Материалы и методы. В исследовании были использованы кролики породы серый великан массой 2500–3100 г, 20 особей, разделенных на доноров (n = 10) и реципиентов (n = 10). После изъятия донорской почки у асистолического донора проводилась процедура гипотермической машинной перфузии ex vivo левой донорской почки раствором на основе декстрана-40 и регистрация показателей периферического сосудистого сопротивления (ПСС), а также последующая билатеральная нефрэктомия и ортотопическая трансплантация. Срок наблюдения составлял 12 суток. В процессе наблюдения оценивали концентрацию креатинина, мочевины, скорость клубочковой фильтрации (СКФ). Результаты. При процедуре гипотермической перфузии донорской почки, полученной от асистолического донора, ex vivo было получено прогрессивное снижение ПСС с 1,90 ± 0,27 до 0,72 ± 0,09 мм рт. ст./мл/мин при р &lt; 0,001. В раннем посттрансплантационном периоде, в течение первых 2 суток после имплантации, значения креатинина и мочевины имели умеренно высокие показатели по сравнению с нормальными. Значения креатинина и мочевины на 2-е сутки составили 91,07 ± 11,49 мкмоль/л при р &lt; 0,011 и 9,09 ± 1,06 ммоль/л при р &lt; 0,009 соответственно, но к 12-м суткам отмечалась регрессия до физиологичных показателей 77,17 ± 10,19 мкмоль/л при р &lt; 0,019 и 4,88 ± 0,54 ммоль/л при р &lt; 0,022 соответственно. Данные результаты коррелировали с показателями СКФ: от 26,29 до 26,74 мл/мин/1,72 м2 в средних значениях в течение 12 суток наблюдения.</p></sec><sec><title>Заключение</title><p>Заключение. Результаты демонстрируют, что гипотермическая машинная перфузия донорской почки ex vivo с использованием раствора на основе декстрана-40 оказывает положительное влияние на донорский орган после 30 минут тепловой ишемии после асистолии и позволяет достичь удовлетворительной функции трансплантата на протяжении 12 суток наблюдения.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Objective</title><p>Objective: to evaluate the efficacy of hypothermic machine perfusion (HMP) of a donor kidney obtained from a non-heartbeating (NHB) donor, using an experimental dextran-40-based preservation solution, in subsequent orthotopic transplantation in a rabbit model.</p></sec><sec><title>Materials and methods</title><p>Materials and methods. Twenty grey giant rabbits weighing 2,500–3,100 g, divided into donors (n = 10) and recipients (n = 10), were used in the study. After obtaining kidney from an NHB donor, ex vivo HMP of the left donor kidney using a dextran-40-based preservation solution was performed and peripheral vascular resistance (PVR) parameters were measured. This was followed by bilateral nephrectomy and orthotopic transplantation. The follow-up period was 12 days. Creatinine levels, urea levels, and glomerular filtration rate (GFR) were measured during follow-up.</p></sec><sec><title>Results</title><p>Results. During ex vivo HMP of donor kidneys from NHBs, PVR dropped progressively from 1.90 ± 0.27 mmHg/mL/min to 0.72 ± 0.09 mmHg/mL/min at p &lt; 0.001. In the early post-transplant period (during the first 2 days after implantation), creatinine and urea levels were moderately elevated compared to normal. Creatinine and urea levels were 91.07 ± 11.49 μmol/L at p &lt; 0.011 and 9.09 ± 1.06 mmol/L at p &lt; 0.009 on day 2, respectively, but by day 12, they reverted to physiologic values, which were 77.17 ± 10.19 μmol/L at p &lt; 0.019 and 4.88 ± 0.54 mmol/L at p &lt; 0.022, respectively. These findings were correlated with GFR values, which ranged from 26.29 to 26.74 mL/min/1.72 m2 in mean values over the course of a 12-day follow-up period.</p></sec><sec><title>Conclusion</title><p>Conclusion. Ex vivo HMP using dextran-40-based preservation solution has a positive effect on the kidney at 30 minutes of warm ischemia following asystole and achieves satisfactory graft function over 12 days of follow-up.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>трансплантология</kwd><kwd>ортотопическая трансплантация почки</kwd><kwd>гипотермическая перфузия почки ex vivo</kwd><kwd>декстран-40</kwd></kwd-group><kwd-group xml:lang="en"><kwd>transplantology</kwd><kwd>orthotopic kidney transplantation</kwd><kwd>ex vivo hypothermic kidney perfusion</kwd><kwd>dextran 40</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Кабанова CА, Богопольский ПМ. Пересадка почки: история, итоги и перспективы (к 50-летию первой успешной пересадки почки в России). Трансплантология. 2015; 2: 55–56.</mixed-citation><mixed-citation xml:lang="en">Kabanova SA, Bogopol’skiy PM. Kidney transplant: history, results and perspectives (The 50th anniversary of the first successful kidney transplant in Russia). Journal of Transplantology. 2015; 2: 55–56.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Hill NR, Fatoba ST, Oke JL, Hirst JA, O’Callaghan CA, Lasserson DS, Hobbs FD. Global Prevalence of Chronic Kidney Disease – A Systematic Review and Meta-Analysis. PLoS One. 2016; 11 (7): e0158765. doi: 10.1371/journal.pone.0158765.</mixed-citation><mixed-citation xml:lang="en">Hill NR, Fatoba ST, Oke JL, Hirst JA, O’Callaghan CA, Lasserson DS, Hobbs FD. Global Prevalence of Chronic Kidney Disease – A Systematic Review and Meta-Analysis. PLoS One. 2016; 11 (7): e0158765. doi: 10.1371/journal.pone.0158765.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Tsai WC, Wu HY, Peng YS, Ko MJ, Wu MS, Hung KY et al. Risk Factors for Development and Progression of Chronic Kidney Disease: A Systematic Review and Exploratory Meta-Analysis. Medicine (Baltimore). 2016; 95 (11): e3013. doi: 10.1097/MD.0000000000003013.</mixed-citation><mixed-citation xml:lang="en">Tsai WC, Wu HY, Peng YS, Ko MJ, Wu MS, Hung KY et al. Risk Factors for Development and Progression of Chronic Kidney Disease: A Systematic Review and Exploratory Meta-Analysis. Medicine (Baltimore). 2016; 95 (11): e3013. doi: 10.1097/MD.0000000000003013.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Готье СВ, Цирульникова ОМ, Пашков ИВ, Олешкевич ДО, Филатов ИА, Богданов ВК и др. Нормотермическая ex vivo перфузия изолированных легких в эксперименте с использованием отечественного перфузионного аппаратного комплекса. Вестник трансплантологии и искусственных органов. 2022; 24 (2): 94–101. https://doi.org/10.15825/1995-11912022-2-94-101.</mixed-citation><mixed-citation xml:lang="en">Gautier SV, Tsirulnikova OM, Pashkov IV, Oleshkevich DO, Filatov IA, Bogdanov VK et al. Normothermic ex vivo perfusion of isolated lungs in an experiment using a russian-made perfusion system. Russian Journal of Transplantology and Artificial Organs. 2022; 24 (2): 94–101. https://doi.org/10.15825/1995-11912022-2-94-101.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Готье СВ, Пашков ИВ, Богданов ВК, Олешкевич ДО, Бондаренко ДМ, Можейко НП и др. Еx vivo перфузия донорских легких с использованием разработанного раствора с последующей ортотопической левосторонней трансплантацией легкого (экспериментальное исследование). Вестник трансплантологии и искусственных органов. 2023; 25 (2): 158–166. https://doi.org/10.15825/1995-1191-2023-2-158-166.</mixed-citation><mixed-citation xml:lang="en">Gautier SV, Pashkov IV, Bogdanov VK, Oleshkevich DO, Bondarenko DM, Mozheiko NP et al. Normothermic ex vivo lung perfusion using a developed solution followed by orthotopic left lung transplantation (experimental study). Russian Journal of Transplantology and Artificial Organs. 2023; 25 (2): 158–166. https://doi.org/10.15825/1995-1191-2023-2-158-166.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Грудинин НВ, Богданов ВК, Шарапов МГ, Буненков НС, Можейко НП, Гончаров РГ и др. Применение пероксиредоксина для прекондиционирования трансплантата серд ца крысы. Вестник трансплантологии и искусственных органов. 2020; 22 (2): 158–164. https://doi.org/10.15825/1995-1191-2020-2-158-164.</mixed-citation><mixed-citation xml:lang="en">Grudinin NV, Bogdanov VK, Sharapov MG, Bunenkov NS, Mozheiko NP, Goncharov RG et al. Use of peroxiredoxin for preconditioning of heterotopic heart transplantation in a rat. Russian Journal of Transplantology and Artificial Organs. 2020; 22 (2): 158–164. https://doi.org/10.15825/1995-1191-2020-2-158-164.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Суханов АВ. Banff-классификация патологии аллотрансплантата почки. Нефрология и диализ. 2000; 2 (1–2): 58–62.</mixed-citation><mixed-citation xml:lang="en">Suhanov AV. Banff’s Classificaton Of Renal Allograft Pathology. Nephrology and Dialysis. 2000; 2 (1–2): 58–62.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Brat A, de Vries KM, van Heurn EWE, Huurman VAL, de Jongh W, Leuvenink HGD et al. Hypothermic Machine Perfusion as a National Standard Preservation Method for Deceased Donor Kidneys. Transplantation. 2022 May; 106 (5): 1043–1050. doi: 10.1097/TP.0000000000003845.</mixed-citation><mixed-citation xml:lang="en">Brat A, de Vries KM, van Heurn EWE, Huurman VAL, de Jongh W, Leuvenink HGD et al. Hypothermic Machine Perfusion as a National Standard Preservation Method for Deceased Donor Kidneys. Transplantation. 2022 May; 106 (5): 1043–1050. doi: 10.1097/TP.0000000000003845.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Peng P, Ding Z, He Y, Zhang J, Wang X, Yang Z. Hypothermic Machine Perfusion Versus Static Cold Storage in Deceased Donor Kidney Transplantation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Artif Organs. 2019 May; 43 (5): 478–489. doi: 10.1111/aor.13364. Epub 2018 Nov 9. PMID: 30282122.</mixed-citation><mixed-citation xml:lang="en">Peng P, Ding Z, He Y, Zhang J, Wang X, Yang Z. Hypothermic Machine Perfusion Versus Static Cold Storage in Deceased Donor Kidney Transplantation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Artif Organs. 2019 May; 43 (5): 478–489. doi: 10.1111/aor.13364. Epub 2018 Nov 9. PMID: 30282122.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Simona MS, Alessandra V, Emanuela C, Elena T, Michela M, Fulvia G et al. Evaluation of Oxidative Stress and Metabolic Profile in a Preclinical Kidney Transplantation Model According to Different Preservation Modalities. Int J Mol Sci. 2023 Jan 5; 24 (2): 1029. doi: 10.3390/ijms24021029. PMID: 36674540; PMCID: PMC9861050.</mixed-citation><mixed-citation xml:lang="en">Simona MS, Alessandra V, Emanuela C, Elena T, Michela M, Fulvia G et al. Evaluation of Oxidative Stress and Metabolic Profile in a Preclinical Kidney Transplantation Model According to Different Preservation Modalities. Int J Mol Sci. 2023 Jan 5; 24 (2): 1029. doi: 10.3390/ijms24021029. PMID: 36674540; PMCID: PMC9861050.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Zulpaite R, Miknevicius P, Leber B, Strupas K, Stiegler P, Schemmer P. Ex-vivo Kidney Machine Perfusion: Therapeutic Potential. Front Med (Lausanne). 2021 Dec 24; 8: 808719. doi: 10.3389/fmed.2021.808719. PMID: 35004787; PMCID: PMC8741203.</mixed-citation><mixed-citation xml:lang="en">Zulpaite R, Miknevicius P, Leber B, Strupas K, Stiegler P, Schemmer P. Ex-vivo Kidney Machine Perfusion: Therapeutic Potential. Front Med (Lausanne). 2021 Dec 24; 8: 808719. doi: 10.3389/fmed.2021.808719. PMID: 35004787; PMCID: PMC8741203.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Lindell SL, Compagnon P, Mangino MJ, Southard JH. UW Solution for Hypothermic Machine Perfusion of Warm Ischemic Kidneys. Transplantation. 2005 May 27; 79 (10): 1358–1361. doi: 10.1097/01.TP.0000159143.45022.F6.</mixed-citation><mixed-citation xml:lang="en">Lindell SL, Compagnon P, Mangino MJ, Southard JH. UW Solution for Hypothermic Machine Perfusion of Warm Ischemic Kidneys. Transplantation. 2005 May 27; 79 (10): 1358–1361. doi: 10.1097/01.TP.0000159143.45022.F6.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Elliott TR, Nicholson ML, Hosgood SA. Normothermic kidney perfusion: An overview of protocols and strategies. Am J Transplant. 2021 Apr; 21 (4): 1382–1390. doi: 10.1111/ajt.16307. Epub 2020 Sep 25. PMID: 32897651.</mixed-citation><mixed-citation xml:lang="en">Elliott TR, Nicholson ML, Hosgood SA. Normothermic kidney perfusion: An overview of protocols and strategies. Am J Transplant. 2021 Apr; 21 (4): 1382–1390. doi: 10.1111/ajt.16307. Epub 2020 Sep 25. PMID: 32897651.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Campos Pamplona C, Moers C, Leuvenink HGD, van Leeuwen LL. Expanding the Horizons of Pre-Transplant Renal Vascular Assessment Using Ex Vivo Perfusion. Curr Issues Mol Biol. 2023 Jun 29; 45 (7): 5437–5459. doi: 10.3390/cimb45070345. PMID: 37504261; PMCID: PMC10378498.</mixed-citation><mixed-citation xml:lang="en">Campos Pamplona C, Moers C, Leuvenink HGD, van Leeuwen LL. Expanding the Horizons of Pre-Transplant Renal Vascular Assessment Using Ex Vivo Perfusion. Curr Issues Mol Biol. 2023 Jun 29; 45 (7): 5437–5459. doi: 10.3390/cimb45070345. PMID: 37504261; PMCID: PMC10378498.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
